Two Sigma Securities’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Two Sigma Securities’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,700	Closed	-$382K	–	3665
2023 Q2	$382K	Buy	+9,700	New	+$342K	0.01%	1661
2022 Q4	–	Sell	-10,954	Closed	-$197K	–	3449
2022 Q3	$197K	Buy	+10,954	New	+$144K	0.01%	1973
2019 Q2	–	Sell	-16,574	Closed	-$23K	–	2512
2019 Q1	$23K	Buy	+16,574	New	+$23.2K	﹤0.01%	1663

Two Sigma Securities's ISEE Position: Q3 2023 in Review

Two Sigma Securities sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 9,700 shares — an estimated $382K sold.

Two Sigma Securities first reported a position in ISEE in Q1 2019 and held it in 3 quarters. The position peaked at $382K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Two Sigma Securities reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Securities sold 9,700 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $382K.
Two Sigma Securities first reported a position in IVERIC bio, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Two Sigma Securities's IVERIC bio, Inc. Common Stock position peaked at $382K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.